文献速递眼整形与眼眶眼外伤

眼睑及眼周鳞状细胞癌分期更差与死亡风险的临床病理因素

Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma.
PubMed 文献 · Br J Ophthalmol · 2021-04-20

该回顾性病例系列纳入1995至2019年85例眼睑及眼周鳞状细胞癌患者,采用Cox与logistic回归分析风险因素。结果显示45.8%为T4期,2年与5年疾病特异性生存率分别为95.3%和86.4%;低/中分化与更差T分期相关,P63表达及P63与Ki67共表达与更差分期、分化、神经侵犯、转移及疾病特异性死亡相关。

要点

  • 低或中分化眼睑及眼周SCC与更差T分期相关(p=0.001;p=0.008)。
  • P63表达与更差分化、神经侵犯和转移风险相关。
  • T4期、P63表达、P63与Ki67共表达及远处转移与疾病特异性死亡相关。

核心结论

  • 眼睑及眼周SCC患者中P63表达及P63与Ki67共表达可预测更差分期、分化及预后,包括转移和疾病特异性死亡。
  • 本队列患者表现出更具侵袭性的眶侵犯特征和较高的远处转移率。

研究设计与样本

  • 回顾性病例系列,纳入1995至2019年连续85例眼睑及眼周鳞状细胞癌患者。
  • 采用Cox比例风险回归模型和logistic回归模型进行风险因素分析。

主要发现

  • 4例(5.1%)发生淋巴结转移,5例(6.4%)随访期间发生远处转移。
  • 2年和5年疾病特异性生存率分别为95.3%和86.4%。
  • 低分化与更高的复发风险相关(p=0.024)。
  • 疾病特异性死亡在T4期SCC患者中更常见(p=0.038,HR=9.05)。

关键数值与推荐

  • 低或中分化眼睑及眼周SCC与更差T分期相关(p=0.001;p=0.008)。
  • P63表达在T3c或更差分期患者中更常见(p=0.008,OR=3.77)。
  • P63表达单独与更差分化(p=0.029)、更高神经侵犯风险(p=0.042,OR=4.61)和转移(p=0.009,HR=3.99)相关。
  • P63表达(p=0.012,HR=7.80)、P63与Ki67共表达(p=0.007,HR=9.21)及远处转移(p=0.001,HR=11.23)与疾病特异性死亡相关。

临床怎么用

  • 对眼睑及眼周SCC患者应关注组织分化程度以评估T分期风险。
  • P63表达及P63与Ki67共表达可作为预测更差分期、转移和疾病特异性死亡的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical and pathological risk factors for worse T stage and prognosis in eyelid and periocular squamous cell carcinomas (SCCs) remain unclear. P63 was reported to predict a worse prognosis in other SCCs; however, this correlation was not validated in eyelid and periocular SCCs. METHODS: We reported on a retrospective case series of 85 consecutive patients with eyelid and periocular SCCs from 1995 to 2019. Cox proportional hazards regression models and logistic regression models were applied for risk factor analysis. RESULTS: Thirty-nine (45.8%) patients were diagnosed with T4 SCCs. Four (5.1%) patients developed nodal metastasis, and five (6.4%) patients developed distant metastasis during the follow-up. 2-year and 5-year disease-specific survival rates were 95.3% and 86.4%, respectively. Poorly or moderately differentiated eyelid and periocular SCCs were associated with worse T stage (p=0.001; p=0.008). Poor differentiation was associated with a higher risk of recurrence (p=0.024). Disease-specific death was more common in patients with T4 stage SCCs (p=0.038, HR=9.05). P63 expression was more common in patients with T3c or worse stage (p=0.008, OR=3.77). P63 expression alone was associated with worse differentiation (p=0.029), higher risk of perineural invasion (p=0.042, OR=4.61) and metastasis (p=0.009, HR=3.99). P63 expression (p=0.012, HR=7.80), coexpression of P63 and Ki67 (p=0.007, HR=9.21) and distant metastasis (p=0.001, HR=11.23) were associated with disease-specific death. CONCLUSION: Patients presented with more aggressive orbital invasion features and a higher rate of distant metastasis in this cohort. P63 and coexpression of Ki67 predicted a worse stage, differentiation and prognosis, including metastasis and death due to disease.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Luo Y, Chen H, Ge S, et al. Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma. Br J Ophthalmol. 2021. PMID: 33879470. doi:10.1136/bjophthalmol-2020-317546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。